Patent · US Active

Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing

US11066705B2 · kind B2 · utility

0Cited by
113References
22Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 24, 2015
Grant dateJul 20, 2021
Priority date
Expiry dateOct 21, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods of monitoring and measuring dynamic adaptive immune cell responses are provided. High-throughput sequencing of T cell receptor and immunoglobulin loci is used to characterize the breadth of an effector cell response to a stimulus, such as a vaccine or infection. Unique responding effector cell clones and abundance thereof can be determined. Additionally, methods for determining the contribution of responding effector cells to the immunological memory compartment are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.